Wednesday, July 16, 2014
5:00 – 7:00
PM Early Registration
Thursday,
July 17, 2014
12:00 – 12:15 PM Welcome and Introductory Remarks: Satish Garg, MD
PLENARY ONE: Improving Diabetes Outcomes Chair - Matthew Riddle, MD
12:15 –12:40 PM
How
Diabetes Outcomes Have Changed Over the Past 30 Years - Philip
Home, MD AUDIO
12:40 – 1:05 PM
Why
Obese People are Unable to Keep Weight Off after Losing it - Robert Ratner,
MD AUDIO
1:05 –
1:30 PM
What Should Be the Therapeutic Glycemic
Target in Intensive Care Units? - Irl
Hirsch, MD AUDIO
1:30 – 1:55 PM
Contemporary
Pediatric Diabetes Care - Tadej Battelino, MD AUDIO
PLENARY TWO: Controversies in Diabetes
Chair - Robert Ratner, MD
2:50
– 3:15 PM
Should We Count Protein and Fat for Bolus
Insulin Dose? - Howard Wolpert,
MD AUDIO
3:15 – 3:40 PM
Do Postprandial Glycemic Excursions Impact Cardiovascular Risk? - V.
Mohan, MD AUDIO
3:40 –
4:05 PM
Role
of Pramlintide in Diabetes Care - Matthew Riddle, MD AUDIO
4:05 – 4:30 PM
Which Guidelines to Use for Gestational Diabetes – ACOG or ADA? - Linda Barbour, MD AUDIO
Friday,
July 18, 2014
7:55
– 8:05 AM
Welcome and
Introductory Remarks - Satish Garg, MD
PLENARY THREE: Type 1
Diabetes – Immunology and Cell Therapy Chair - Philip Home, MD
8:05 – 8:30 AM
Knowledge gains in type 1 diabetes pathogenesis – New
opportunities for the next generation of disease biomarkers - Mark
Atkinson, PhD AUDIO
8:30 – 8:55 AM
Is Primary Prevention a Realistic Expectation? - Marian
Rewers, PHD AUDIO
8:55 –
9:20 AM
Immunomodulatory
Trials; What Will Work? - Peter Gottlieb, MD AUDIO
9:20 – 9:45 AM
Tri-Molecular
Complex for Immune Intervention? - Aaron
Michels, MD AUDIO
9:45 –10:10 AM
Beta-Cell Regeneration or Replacement – Hype or Hope? - Jay Skyler,
MD AUDIO
PLENARY FOUR: Closed
Loop Therapy – State of the Art Chair - Georgeanna Klingensmith, MD
10:50 –11:15
AM
Early Closed Loop Experience in Children - Tadej
Battelino, MD AUDIO
11:15 –11:40
AM
Wearable Artificial Pancreas - Boris Kovatchev, PhD AUDIO
11:40 –12:05 PM
Making Diabetes Management Disappear: A Bionic Pancreas for One and All - Ed Damiano, PhD AUDIO
12:05 –12:30 PM
The Role of Glucagon in Closed Loop
Treatment for T1D - Kenneth Ward, MD AUDIO
PLENARY FIVE: Diabetes
Management Issues Chair - Sarit Polsky, MD
2:00 – 2:25 PM
Hypoglycemic
Unawareness - Philip Home, MD AUDIO
2:25 – 2:50 PM
Explanation for the
ACCORD Outcomes? - Matthew
Riddle, MD AUDIO
2:50 – 3:15 PM
How to Successfully Manage T1DM in the Cheapest Way Possible - Irl Hirsch, MD AUDIO
4:00 – 5:00 PM MEET THE PEERS SESSION (A&B
Pediatrics, C&D Adult)
Session A. & B. Meet the Peers – Pediatric
A. Providers: Chairs - T. Battelino & R. Slover
B. Educators: Chair - R. Hink
Session C. & D. Meet the Peers – Adult
C. Providers: Chairs - P. Home & S. Garg
D. Educators: Chairs - C. Beatson & T.
Thompson
Saturday, July 19, 2014
7:50 – 7:55
AM
Welcome and Introductory Remarks - Satish Garg, MD
7:55 – 8:25 AM
FDA’s Perspective on Closed-Loop Studies - AUDIO
Keynote Speaker: Courtney H. Lias,
PhD; Director, Division of Chemistry and Toxicology
Devices at FDA
PLENARY SIX: Special
Issues in Diabetes Chair - Irl Hirsch, MD
8:35 – 9:00 AM
Role of Biosimilars in Diabetes Care - Philip Home,
MD AUDIO
9:00 –
9:25 AM
Role of CGM for
Achieving Glycemic Targets - Howard Wolpert, MD AUDIO
9:25
– 9:50 AM
Fibrocalculous
Pancreatic Diabetes - V. Mohan, MD AUDIO
9:50 – 10:10 AM
Management of T1D Using Telemedicine - Paul Wadwa, MD AUDIO
PLENARY
SEVEN: Obesity and Type 2 Diabetes Chair - Linda Barbour, MD
10:45
–11:10 AM
Role of Lifestyle Modifications - James
Hill, PhD AUDIO
11:10 –11:35 AM
Pharmacological Approaches to
Weight Loss - Daniel Bessesen, MD AUDIO
11:35 –12:00 PM
Role of Bariatric Surgery in Obesity
& Diabetes - Phillip Schauer, MD AUDIO
12:00 –12:30 PM
Novel Approaches to Weight
Loss - Robert Eckel, MD AUDIO
2:00
– 4:00 PM CONCURRENT SESSIONS 1 & 2
SESSION 1: Pediatric Diabetes
Challenges Chair - Robert Slover, MD AUDIO
2:00
– 2:20 PM
Toddlers - Peter Chase,
MD
2:20
– 2:40 PM
Teenagers - G. Klingensmith, MD
2:40 – 3:00 PM
T2D in Youth - Tadej Battelino, MD
SESSION 2: Challenges with Diabetes
Complications Chair - Satish Garg, MD AUDIO
2:00 – 2:20
PM
Microvascular - Jay Skyler,
MD
2:20 – 2:40
PM
Macrovascular - Will Hiatt,
MD
2:40 – 3:00
PM
Neuropathy - Daniel Bessesen, MD
Patient/Provider Panel: Question &
Answer Session
4:00 – 5:15 PM
Pediatric
Panel:
R. Slover, G. Klingensmith, P. Chase, T. Battelino, M. Rewers
Patients:
-Mollendor Family
-Zarecki Family
-Mario Medina
Adult Panel: S. Garg, A. Michels, J.
Skyler, P. Gottlieb, H. Wolpert, I. Hirsch
Patients:
-Adam Smith
-Ted Miller
-Duncan Harvey &
Robin Juarez
-Clark Eckel
-Lynda Bergeron
Sunday, July 20, 2014
7:20 – 7:30
AM
Opening Remarks - Satish Garg, MD and Jay Skyler, MD
7:30
– 8:00 AM
Delivery of Quality Care
in the Evolving Payor Landscape:
Keynote Speaker: Robert Ratner, MD AUDIO
PLENARY
EIGHT: Cardiovascular Disease and
Diabetes Chair - Marian Rewers, PHD
8:00
– 8:25 AM
Is
CVD Outcome for Diabetes Drugs
Appropriate? - Will Hiatt, MD AUDIO
8:25 – 8:50 AM
Recent
and Ongoing Cardiovascular Outcomes Trials with Diabetes Drugs - Jay Skyler,
MD AUDIO
8:50 – 9:15
AM
Rationale for ADA Treatment
Guidelines for CVD Prevention - Robert Ratner, MD AUDIO
9:15 –
9:40 AM
Lipid Targets &
Treatments 2014 - Robert Eckel, MD AUDIO
10:10
–10:15 AM
Concluding Remarks &
Departures - Satish Garg, MD